Associated Papers
Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus.
Jeanpierre M et al.
The Journal of Experimental Medicine, 2024
39028869 (PubMed )
Supplement: JEM_20232337_TableS4.xlsx › Table._Supp4
JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review.
Atschekzei F et al.
Frontiers in Immunology, 2024
39247195 (PubMed )
Supplement: DataSheet1.pdf
Novel STAT3 variant causing infantile-onset autoimmune disease.
Pan M et al.
Frontiers in Medicine, 2023
Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function.
Kaneko S et al.
Immunotherapy Advances, 2023
Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
Tanita K et al.
Journal of Clinical Immunology, 2021
Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
Tanita K et al.
Journal of Clinical Immunology, 2021
The molecular skin pathology of familial primary localized cutaneous amyloidosis.
Tanaka A et al.
Experimental Dermatology, 2010
Select a paper to view details